You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Harnessing Microglia and Macrophages for the Treatment of Glioblastoma
|
|---|---|
| Published in |
Frontiers in Pharmacology, June 2019
|
| DOI | 10.3389/fphar.2019.00506 |
| Pubmed ID | |
| Authors |
Ioanna Prionisti, Léo H. Bühler, Paul R. Walker, Renaud B. Jolivet |
X Demographics
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 22% |
| France | 1 | 6% |
| Canada | 1 | 6% |
| India | 1 | 6% |
| Montenegro | 1 | 6% |
| Lebanon | 1 | 6% |
| Sao Tome and Principe | 1 | 6% |
| Austria | 1 | 6% |
| Switzerland | 1 | 6% |
| Other | 1 | 6% |
| Unknown | 5 | 28% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 14 | 78% |
| Scientists | 3 | 17% |
| Practitioners (doctors, other healthcare professionals) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 141 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 141 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 35 | 25% |
| Researcher | 18 | 13% |
| Student > Master | 11 | 8% |
| Student > Bachelor | 10 | 7% |
| Student > Doctoral Student | 8 | 6% |
| Other | 17 | 12% |
| Unknown | 42 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 24 | 17% |
| Neuroscience | 21 | 15% |
| Medicine and Dentistry | 17 | 12% |
| Agricultural and Biological Sciences | 9 | 6% |
| Immunology and Microbiology | 7 | 5% |
| Other | 13 | 9% |
| Unknown | 50 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2020.
All research outputs
#3,333,072
of 23,340,595 outputs
Outputs from Frontiers in Pharmacology
#1,594
of 16,802 outputs
Outputs of similar age
#71,291
of 353,383 outputs
Outputs of similar age from Frontiers in Pharmacology
#56
of 349 outputs
Altmetric has tracked 23,340,595 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,802 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,383 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 349 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.